サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1402537

北米の目薬市場の2030年予測-地域別分析-タイプ、用途、購入形態別

North America Eye Drops Market Forecast to 2030 - Regional Analysis - by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application, and Purchase Mode (OTC and Prescription)
出版日: | 発行: The Insight Partners | ページ情報: 英文 87 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
北米の目薬市場の2030年予測-地域別分析-タイプ、用途、購入形態別
出版日: 2023年11月07日
発行: The Insight Partners
ページ情報: 英文 87 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の目薬市場は、2022年の80億3,088万米ドルから2030年には122億8,912万米ドルに成長すると予測されています。2022年から2030年までのCAGRは5.5%と推定されます。

眼科疾患の有病率の上昇が北米の点眼薬市場を後押し

視力障害につながる糖尿病性網膜症、緑内障、ドライアイなどの眼科疾患の罹患率は、特に先進国で増加しています。ドライアイは、不快感、刺激、視覚障害をもたらす複数の要因によって引き起こされます。2020年4月に米国で実施された調査「National Health and Wellness Survey」によると、1,640万人がドライアイと診断されました。また、18～34歳の有病率が2.7％急増したとのデータもあります。Novaliq GmbHによると、現在約1700万人のアメリカ人がドライアイに苦しんでいます。

糖尿病網膜症は、微小血管の末端器官障害です。糖尿病網膜症は、非増殖糖尿病網膜症の段階から増殖糖尿病網膜症へと進行します。糖尿病網膜症が進行すると、それに伴う糖尿病黄斑浮腫も明らかになることがあります。米国眼科学会が発表した論文によると、2030年までに全世界で推定1億9,100万人が糖尿病網膜症に罹患すると推定されています。Medscapeによると、米国では約70万人が増殖糖尿病網膜症に罹患しており、毎年約6万5,000人が新たに発症しています。

世界保健機関（WHO）が2022年に発表した論文によると、世界中で約22億人が近見または遠見の視力障害に苦しんでいます。視力障害の主要原因は、白内障（約9,400万件）と未矯正の屈折異常（約8,840万件）です。医師は通常、眼科疾患の治療と予防のために目薬を処方します。したがって、眼科疾患の有病率の増加が北米の点眼薬市場の成長を促進しています。

北米の目薬市場概要

北米の目薬市場は米国、カナダ、メキシコに区分されます。この地域の市場成長の背景には、ドライアイ疾患に対する意識の高まり、高齢化人口の増加、眼疾患の罹患率上昇に伴う眼科治療手技の技術進歩があります。ドライアイ疾患は米国では一般的な疾患であるが、診断が不十分です。高齢者人口の増加がドライアイ疾患の有病率をさらに高めています。米国疾病予防管理センター（CDC）によると、黄斑変性症、白内障、糖尿病性網膜症、緑内障などの加齢に伴う眼疾患は、米国における失明や弱視の主要原因となっています。その他、弱視や斜視などの一般的な眼疾患も報告されています。人口の高齢化と若年層が屈折矯正手術を受ける頻度の増加に伴い、ドライアイは2030年までに米国で279万人もの男性が罹患すると予想されています。

米国は北米の点眼薬市場において最大かつ最も急成長している国です。この国の市場は、人々の間でドライアイ疾患が増加していることに起因しています。米国には、ドライアイを治療するためのさまざまな点眼薬やレンズを提供する企業が進出しています。また、医療支出が増加していることも、米国における北米点眼薬市場の成長を後押ししています。

北米の目薬市場の収益と2030年までの予測（金額）

北米の目薬市場セグメンテーション

北米の目薬市場は、タイプ、用途、購入形態、国に区分されます。

タイプ別では、北米の目薬市場は抗生物質、人工涙液、ホルモン剤、その他に区分されます。2022年の北米の目薬市場では、抗生物質分野が最大シェアを占めています。

用途別では、北米の目薬市場は眼病、アイケア、その他に区分されます。眼疾患セグメントは2022年に北米の目薬市場で最大のシェアを占めました。眼疾患セグメントはさらにドライアイ、緑内障、白内障、その他に区分されます。

購入形態に基づき、北米の目薬市場は市販薬と処方箋に区分されます。2022年の北米点眼薬市場では、処方箋セグメントが大きなシェアを占めています。

国別では、北米の目薬市場は米国、カナダ、メキシコに区分されます。2022年の北米点眼薬市場は米国が支配的でした。

AbbVie Inc、Akorn Operating Company LLC、Alcon AG、Bausch &Lomb Inc、Pfizer Inc、Prestige Consumer Healthcare Inc、Rohto Pharmaceutical Co Ltd、Similasan Corpは、北米の目薬市場で事業を展開している大手企業です。

目次

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の目薬市場情勢

  • 概観
  • PEST分析
    • 北米PEST分析
  • パイプライン分析
  • 購入モード

第5章 北米点眼薬市場：主要産業力学

  • 市場促進要因
    • 眼科疾患の有病率の上昇
    • 加齢に伴う眼疾患の高い発生率
  • 市場抑制要因
    • 製品回収
  • 市場機会
    • アイケアへの取り組みの高まり
  • 今後の動向
    • ライフスタイルの変化
  • 影響分析

第6章 目薬市場：北米市場分析

  • 北米の目薬市場売上高推移（2022～2030年）

第7章 北米の目薬市場：2030年までの収益と予測：タイプ別

  • イントロダクション
  • 北米の目薬市場：2022年・2030年のタイプ別売上高シェア（%）
  • 抗生物質
  • 人工涙液
  • ホルモン剤
  • その他

第8章 北米の目薬市場：2030年までの収益と予測：用途別

  • イントロダクション
  • 北米の目薬市場：2022年・2030年の用途別売上高シェア（%）
  • 眼疾患
  • アイケア
  • その他

第9章 北米の目薬市場：2030年までの収益と予測：購入形態別

  • イントロダクション
  • 北米の目薬市場：2022年・2030年の購入形態別売上高シェア（%）
  • 処方薬
  • 市販薬

第10章 北米の目薬市場～2030年までの収益と予測：国別分析

第11章 北米の目薬市場-業界情勢

  • イントロダクション
  • 目薬市場における成長戦略（%）
  • 有機的展開
  • 概要
  • 無機的展開
  • 概要

第12章 企業プロファイル

  • Akorn Operating Company LLC
  • Alcon AG
  • Pfizer Inc
  • Prestige Consumer Healthcare Inc.
  • Rohto Pharmaceutical Co Ltd
  • Similasan Corp
  • AbbVie Inc
  • Bausch & Lomb Inc

第13章 付録

図表

List Of Tables

List of Tables

  • Table 1. North America Eye Drops Market Segmentation
  • Table 2. US: North America Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US: North America Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US: North America Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US: North America Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Canada: North America Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada: North America Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada: North America Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada: North America Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Mexico: North America Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Mexico: North America Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Mexico: North America Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico: North America Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Organic Developments in the Eye Drops Market
  • Table 15. Inorganic Developments in the Eye Drops Market
  • Table 16. Glossary of Terms, North America Eye Drops Market

List Of Figures

List of Figures

  • Figure 1. North America Eye Drops Market Segmentation, By Country
  • Figure 2. North America - PEST Analysis
  • Figure 3. Pipeline Analysis
  • Figure 4. North America Eye Drops Market: Key Industry Dynamics
  • Figure 5. North America Eye Drops Market: Impact Analysis of Drivers and Restraints
  • Figure 6. North America Eye Drops Market Revenue (US$ Mn), 2020 - 2030
  • Figure 7. North America Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 8. Antibiotics: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Artificial Tears: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Hormones: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. North America Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 13. Eye Diseases: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Dry Eye: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Glaucoma: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Cataract: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Eye Care: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
  • Figure 21. Prescription: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. OTC: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. North America Eye Drops Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. North America Eye Drops Market, by Country, 2022 & 2030 (%)
  • Figure 25. US: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Canada: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Mexico: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Growth Strategies in the Eye Drops Market (%)
目次
Product Code: BMIRE00029070

The North America eye drops market is expected to grow from US$ 8,030.88 million in 2022 to US$ 12,289.12 million by 2030. It is estimated to grow at a CAGR of 5.5% from 2022 to 2030.

Rising Prevalence of Ophthalmic Diseases Fuels North America Eye Drops Market

The incidence of ophthalmic diseases such as diabetic retinopathy, glaucoma, and dry eye leading to vision impairment is rising among the population, especially in developed countries. A dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. According to a study, "National Health and Wellness Survey," conducted in the US in April 2020, ~16.4 million people were diagnosed with dry eye. The data also stated that the prevalence had surged by 2.7% among people aged 18-34 years. According to Novaliq GmbH, ~17 million Americans currently suffer from dry eye disease.

Diabetic retinopathy represents microvascular end-organ damage. It progresses from non-proliferative diabetic retinopathy stages to proliferative diabetic retinopathy. As the disease progresses, associated diabetic macular edema may also become apparent. According to an article published by the American Academy of Ophthalmology, it is estimated that by 2030 an estimated 191 million people globally will suffer from diabetic retinopathy. According to Medscape, ~700,000 people in the US suffer from proliferative diabetic retinopathy, with ~65,000 new cases recorded annually.

According to an article published by the World Health Organization (WHO) in 2022, ~2.2 billion people worldwide suffer from near or distant vision impairment. The leading causes of vision impairment are cataracts (~94 million cases) and uncorrected refractive errors (~88.4 million cases). Doctors generally prescribe eye drops for the treatment and prevention of ophthalmic diseases. Hence, the increasing prevalence of ophthalmic diseases is fueling the growth of the North America eye drops market .

North America Eye Drops Market Overview

The North America eye drops market has been segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the rising awareness of dry eye conditions, an increase in the aging population, and technological advancements in eye treatment procedures with the rising incidence of eye disorders. Dry eye disease is a common but underdiagnosed condition in the US. The growing geriatric population further triggers the prevalence of dry eye disease. According to the Centers for Disease Control and Prevention (CDC), age-related eye diseases such as macular degeneration, cataract, diabetic retinopathy, and glaucoma are the leading causes of blindness and low vision in the US. Other common eye disorders reported in the country include amblyopia and strabismus. With aging populations and the increased frequency of younger adults receiving refractive surgeries, dry eye is expected to affect as many as 2.79 million men in the US by 2030.

The US is the largest and fastest-growing country in the North America eye drops market. The market in this country is ascribed to the increasing incidence of dry eye disease among people. Various companies offering different eye drops and lenses to treat dry eye condition have presence in the US. Also, the rising healthcare expenditure favors the growth of the North America eye drops market in the US.

North America Eye Drops Market Revenue and Forecast to 2030 (US$ Million)

North America Eye Drops Market Segmentation

The North America eye drops market is segmented into type, application, purchase mode, and country.

Based on type, the North America eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the North America eye drops market in 2022.

Based on application, the North America eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the North America eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.

Based on purchase mode, the North America eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the North America eye drops market in 2022.

Based on country, the North America eye drops market is segmented into the US, Canada, and Mexico. The US dominated the North America eye drops market in 2022.

AbbVie Inc, Akorn Operating Company LLC, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, Prestige Consumer Healthcare Inc., Rohto Pharmaceutical Co Ltd, and Similasan Corp are some of the leading companies operating in the North America eye drops market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Eye Drops Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

Table of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Eye Drops Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
  • 4.3 Pipeline Analysis
  • 4.4 Purchase Mode

5. North America Eye Drops Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Ophthalmic Diseases
    • 5.1.2 High Incidence of Age-Related Eye Diseases
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
  • 5.3 Market Opportunities
    • 5.3.1 Rising Initiatives for Eye Care
  • 5.4 Future Trends
    • 5.4.1 Changing Lifestyle
  • 5.5 Impact Analysis

6. Eye Drops Market - North America Market Analysis

  • 6.1 North America Eye Drops Market Revenue (US$ Mn), 2022 - 2030

7. North America Eye Drops Market - Revenue and Forecast to 2030 - by Type

  • 7.1 Overview
  • 7.2 North America Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
  • 7.3 Antibiotics
    • 7.3.1 Overview
    • 7.3.2 Antibiotics: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Artificial Tears
    • 7.4.1 Overview
    • 7.4.2 Artificial Tears: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Hormones
    • 7.5.1 Overview
    • 7.5.2 Hormones: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Eye Drops Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 North America Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Eye Diseases
    • 8.3.1 Overview
    • 8.3.2 Eye Diseases: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 Dry Eye
        • 8.3.2.1.1 Overview
      • 8.3.2.2 Dry Eye: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.3 Glaucoma
        • 8.3.2.3.1 Overview
        • 8.3.2.3.2 Glaucoma: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.4 Cataract
        • 8.3.2.4.1 Overview
        • 8.3.2.4.2 Cataract: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.5 Others
        • 8.3.2.5.1 Overview
        • 8.3.2.5.2 Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Eye Care
    • 8.4.1 Overview
    • 8.4.2 Eye Care: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Eye Drops Market - Revenue and Forecast to 2030 - by Purchase Mode

  • 9.1 Overview
  • 9.2 North America Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
  • 9.3 Prescription
    • 9.3.1 Overview
    • 9.3.2 Prescription: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 OTC
    • 9.4.1 Overview
    • 9.4.2 OTC: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Eye Drops Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 North America Eye Drops Market
    • 10.1.1 Overview
      • 10.1.1.1 US: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 US: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 US: North America Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 10.1.1.1.4 US: North America Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.1.4.1 US: North America Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 10.1.1.1.5 US: North America Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 10.1.1.2 Canada: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Canada: North America Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Canada: North America Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.4.1 Canada: North America Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.5 Canada: North America Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 10.1.1.3 Mexico: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 Mexico: North America Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Mexico: North America Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.4.1 Mexico: North America Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.5 Mexico: North America Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)

11. North America Eye Drops Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Eye Drops Market (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Akorn Operating Company LLC
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Alcon AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Pfizer Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Prestige Consumer Healthcare Inc.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Rohto Pharmaceutical Co Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Similasan Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 AbbVie Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Bausch & Lomb Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms